Revvity (NYSE:RVTY) Given “Peer Perform” Rating at Wolfe Research

Revvity (NYSE:RVTYGet Free Report)‘s stock had its “peer perform” rating reaffirmed by equities researchers at Wolfe Research in a note issued to investors on Tuesday,Benzinga reports.

A number of other research analysts have also weighed in on RVTY. Robert W. Baird set a $117.00 target price on Revvity in a report on Wednesday, May 6th. Stifel Nicolaus dropped their target price on Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a report on Wednesday, May 6th. Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a report on Saturday, April 18th. TD Cowen raised their target price on Revvity from $115.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Finally, JPMorgan Chase & Co. dropped their target price on Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a report on Wednesday, May 6th. Four equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $107.73.

Get Our Latest Research Report on Revvity

Revvity Trading Down 3.9%

Shares of Revvity stock opened at $100.44 on Tuesday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 1.72. Revvity has a 52 week low of $81.22 and a 52 week high of $118.30. The stock has a 50 day moving average price of $92.32 and a two-hundred day moving average price of $97.31. The stock has a market capitalization of $11.21 billion, a PE ratio of 48.06, a price-to-earnings-growth ratio of 2.25 and a beta of 1.11.

Revvity (NYSE:RVTYGet Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 EPS for the quarter, beating analysts’ consensus estimates of $1.02 by $0.04. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The firm had revenue of $711.12 million during the quarter, compared to analysts’ expectations of $704.07 million. During the same quarter last year, the firm posted $1.01 earnings per share. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. As a group, equities analysts anticipate that Revvity will post 5.32 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Ascentis Independent Advisors purchased a new position in Revvity in the first quarter worth $29,000. CYBER HORNET ETFs LLC purchased a new position in Revvity in the second quarter worth $32,000. Cromwell Holdings LLC boosted its position in Revvity by 141.4% in the fourth quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock worth $33,000 after purchasing an additional 198 shares during the last quarter. MUFG Securities EMEA plc purchased a new position in Revvity in the second quarter worth $34,000. Finally, SJS Investment Consulting Inc. boosted its position in Revvity by 5,210.0% in the first quarter. SJS Investment Consulting Inc. now owns 531 shares of the company’s stock worth $47,000 after purchasing an additional 521 shares during the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.

About Revvity

(Get Free Report)

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

Read More

Analyst Recommendations for Revvity (NYSE:RVTY)

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.